Element Biosciences Partners with Dovetail Genomics to Validate its Proximity Ligation-Based NGS Library Prep Solutions for Epigenetics on Element’s AVITI™ System

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Dovetail Genomics demonstrating the value and performance of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System.

The ability to unlock access to genomic structure enables cutting-edge science in the fields of epigenetics, developmental biology, cancer research, conservation and evolutionary biology. Advances in chromatin conformation capture technologies sit at the forefront of this effort. Dovetail Genomics’ best-in-class products and services capture 3D genome architecture alongside primary sequence information using NGS approaches.

“We are pleased to form a partnership with Dovetail Genomics to deliver seamless compatibility between the AVITI System and Dovetail’s library preparation kits. Their proximity ligation technology couples well with Element’s improvements in sequencing accuracy, lower optical duplication rate and consistency of data, across a range of applications,” said Shawn Levy, Senior Vice President of Applications and Scientific Affairs at Element Biosciences.

“We are thrilled to partner with Element Biosciences to add Dovetail Genomics’ cutting-edge proximity ligation technology to this new and exciting NGS platform,” said Dovetail CEO Todd Dickinson. “The long-range, unbiased nature of the Dovetail data opens up many new applications not typically accessible with a short-read platform, offering a richer view of the genome from every sequencing run.”

To learn more about the AVITI System, including detailed specifications, application data, and performance testimonials, register now for Element’s virtual event on March 14th, 9 a.m. PT / 5 p.m. CET, at https://registration.elementbiosciences.com/.

About Dovetail Genomics
Dovetail Genomics is reimagining the life sciences by unlocking access to genomic structure at an unparalleled level. Through Dovetail Genomics' proprietary proximity ligation technologies, the 3D architecture of the genome is captured alongside primary sequence information using standard next-generation sequencing (NGS) approaches. Researchers are using Dovetail Genomics' unique methods to solve complex problems including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing and microbiome analysis in the fields of epigenetics, developmental biology, cancer research, evolutionary biology and more. For more information on Dovetail, its technology, and service offerings, visit www.dovetailgenomics.com. Follow Dovetail on Twitter @DTGenomics.

About Element Biosciences, Inc.
Element Biosciences is a multi-disciplinary life science company currently focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Through innovating every fundamental element of a sequencing system, Element will empower customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic medicine. To learn more about Element, please visit www.elementbiosciences.com.